Duke Cancer Institute-labeled light blue binder

GU Public Symposium Includes Celebration of Berry's Retirement







Trent Semans Center - Great Hall (on Duke campus)
8 Searle Center Dr.
Durham, NC
This event has passed.
Two men in suits pose in a conference hall
Andrew Armstrong, MD, and William Berry, MD


On September 29, community members, including cancer survivors and caregivers, learned about the latest clinical advances in the treatment of kidney, prostate, and bladder cancers during a live discussion among faculty/oncologists from the Duke Cancer Institute Center for Prostate & Urologic Cancers.

Speakers included: William Berry, MD; Daniel George, MD; Michael Harrison, MD; Zach Reitman, MD, PhD; Ankeet Shah, MD; Michael Abern, MD; Andrew Armstrong, MD, MSc; Ryan Fecteau, MD, PhD; Christopher Hoimes, DO; Shahla Bari, MBBS; and Hannah McManus, MD.

In a special session of the symposium William Berry, MD, was celebrated for his five-decade career in Medicine — beginning and ending at Duke — and interviewed by George. Berry, a DCI medical oncologist specializing in treating bladder, kidney, prostate, and testicular cancer, joined Duke on January 1, 1974, and will officially retire on Dec. 31, 2023. He earned his MD at Duke in 1973.

Together, the 2023 Duke Cancer Institute Center for Prostate & Urologic Cancers Symposium (9/29/23) and Tackle Cancer Tailgate (9/30/23) raised $64,000 for prostate and urologic cancer research.

Duke in the 1970s black and white slide of five young men in front of a stone building
This slide was shown as part of a tribute to William Berry, MD, to illustrate Duke in the 1970s when he began his medical career.